134 related articles for article (PubMed ID: 9236429)
1. Intracoronary angiotensin II potentiates coronary sympathetic vasoconstriction in humans.
Saino A; Pomidossi G; Perondi R; Valentini R; Rimini A; Di Francesco L; Mancia G
Circulation; 1997 Jul; 96(1):148-53. PubMed ID: 9236429
[TBL] [Abstract][Full Text] [Related]
2. ACE inhibition attenuates sympathetic coronary vasoconstriction in patients with coronary artery disease.
Perondi R; Saino A; Tio RA; Pomidossi G; Gregorini L; Alessio P; Morganti A; Zanchetti A; Mancia G
Circulation; 1992 Jun; 85(6):2004-13. PubMed ID: 1591820
[TBL] [Abstract][Full Text] [Related]
3. Modulation of sympathetic coronary vasoconstriction by cardiac renin-angiotensin system in human coronary heart disease.
Saino A; Pomidossi G; Perondi R; Morganti A; Turolo L; Mancia G
Circulation; 2000 May; 101(19):2277-83. PubMed ID: 10811595
[TBL] [Abstract][Full Text] [Related]
4. Effects of amlodipine on coronary hemodynamics and vascular responses to sympathetic stimulation in patients with coronary heart disease.
Saino A; Pomidossi G; Perondi R; Gregorini L; Rimini A; Alessio P; Zanchetti A; Mancia G
J Cardiovasc Pharmacol; 1994 Dec; 24(6):875-82. PubMed ID: 7898068
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibition restores flow-dependent and cold pressor test-induced dilations in coronary arteries of hypertensive patients.
Antony I; Lerebours G; Nitenberg A
Circulation; 1996 Dec; 94(12):3115-22. PubMed ID: 8989118
[TBL] [Abstract][Full Text] [Related]
6. Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction.
van Esch JH; Tom B; Dive V; Batenburg WW; Georgiadis D; Yiotakis A; van Gool JM; de Bruijn RJ; de Vries R; Danser AH
Hypertension; 2005 Jan; 45(1):120-5. PubMed ID: 15583077
[TBL] [Abstract][Full Text] [Related]
7. Regional renal haemodynamics of angiotensin II infusion under prostaglandin, kinin or converting enzyme inhibition in the Wistar rat.
Rudenstam J; Creutz J; Göthberg G; Karlström G; Bergström G
Blood Press; 2000; 9(2-3):169-75. PubMed ID: 10855742
[TBL] [Abstract][Full Text] [Related]
8. The cardiac effects of intracoronary angiotensin II infusion.
Broomé M; Haney M; Osterlund B; Häggmark S; Johansson G; Biber B
Anesth Analg; 2002 Apr; 94(4):787-93, table of contents. PubMed ID: 11916774
[TBL] [Abstract][Full Text] [Related]
9. Effects of converting enzyme inhibitors on coronary flow and myocardial ischemia.
van Gilst WH; Tio RA; van Wijngaarden J; de Graeff PA; Wesseling H
J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S134-9. PubMed ID: 1381790
[TBL] [Abstract][Full Text] [Related]
10. Swimming training prevents fat deposition and decreases angiotensin II-induced coronary vasoconstriction in ovariectomized rats.
Endlich PW; Claudio ER; da Silva Gonçalves WL; Gouvêa SA; Moysés MR; de Abreu GR
Peptides; 2013 Sep; 47():29-35. PubMed ID: 23792185
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of angiotensin II-mediated coronary vasoconstriction and vasodilatory action of angiotensin-converting enzyme inhibitor in pacing-induced heart failure in dogs.
Oikawa Y; Maehara K; Saito T; Tamagawa K; Maruyama Y
J Am Coll Cardiol; 2001 Oct; 38(4):1188-94. PubMed ID: 11583902
[TBL] [Abstract][Full Text] [Related]
12. Vasoconstriction by in situ formed angiotensin II: role of ACE and chymase.
MaassenVanDenBrink A; de Vries R; Saxena PR; Schalekamp MA; Danser AH
Cardiovasc Res; 1999 Nov; 44(2):407-15. PubMed ID: 10690317
[TBL] [Abstract][Full Text] [Related]
13. Splanchnic vasoconstriction by angiotensin II is arterial pressure dependent.
Broomé M; Aneman A; Lehtipalo S; Arnerlöv C; Johansson G; Winsö O; Biber B
Acta Anaesthesiol Scand; 2002 Jan; 46(1):57-63. PubMed ID: 11903073
[TBL] [Abstract][Full Text] [Related]
14. Coronary vascular reactivity and calcium antagonist therapy in patients with angina.
Perondi R; Saino A; Zanchetti A; Mancia G
J Cardiovasc Pharmacol; 1994; 24 Suppl A():S30-6. PubMed ID: 7603075
[TBL] [Abstract][Full Text] [Related]
15. Long-term nitroglycerin treatment is associated with supersensitivity to vasoconstrictors in men with stable coronary artery disease: prevention by concomitant treatment with captopril.
Heitzer T; Just H; Brockhoff C; Meinertz T; Olschewski M; Münzel T
J Am Coll Cardiol; 1998 Jan; 31(1):83-8. PubMed ID: 9426022
[TBL] [Abstract][Full Text] [Related]
16. Coronary vasodilation to acetylcholine, adenosine and bradykinin in dogs: effects of inhibition of NO-synthesis and captopril.
Zanzinger J; Bassenge E
Eur Heart J; 1993 Nov; 14 Suppl I():164-8. PubMed ID: 8293769
[TBL] [Abstract][Full Text] [Related]
17. Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test.
Nabel EG; Ganz P; Gordon JB; Alexander RW; Selwyn AP
Circulation; 1988 Jan; 77(1):43-52. PubMed ID: 2826047
[TBL] [Abstract][Full Text] [Related]
18. Participation of prostaglandins and bradykinin in the effects of angiotensin II and converting enzyme-inhibition on sympathetic neurotransmission in vivo.
Schwieler JH; Kahan T; Nussberger J; Hjemdahl P
Acta Physiol Scand; 1994 Sep; 152(1):83-91. PubMed ID: 7810335
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II and cardiovascular chemoreflex responses to acute hypoxia in late gestation fetal sheep.
Green LR; McGarrigle HH; Bennet L; Hanson MA
J Physiol; 1998 Mar; 507 ( Pt 3)(Pt 3):857-67. PubMed ID: 9508845
[TBL] [Abstract][Full Text] [Related]
20. Separation of peripheral and central cardiovascular actions of angiotensin II.
Kooner JS; May CN; Peart S; Mathias CJ
Am J Physiol; 1997 Dec; 273(6):H2620-6. PubMed ID: 9435595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
